ODYSSEY WORKSTATION— 510(k) K093092

Name: FDA 510(k) clearance K093092
Creator: U.S. Food and Drug Administration
Published: 2010-01-21

Substantially Equivalent

Stereotaxis, Inc.

FDA 510(k) clearance K093092 for ODYSSEY WORKSTATION, Substantially Equivalent on 2010-01-21. Applicant: Stereotaxis, Inc.. Device class: 2.

Clearance details

Applicant: Stereotaxis, Inc.
Product code: Code DQK
Device class: Class 2
Regulation: 21 CFR 870.1425
Advisory panel: Cardiovascular
Date received: 2009-10-01
Decision date: 2010-01-21
Decision: Substantially Equivalent
Clearance type: Special
Location: St. Louis, MO, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DQK

view all

K253692 — AVVIGO+ Multi-Modality Guidance System2026-08-21
K262005 — Affera Integrated Mapping System2026-08-21
K253576 — CorVista System® with PCWP Add-On2026-07-26
K262006 — EnSite X EP System2026-07-15
K252978 — ScioCardio ECG Analysis Platform2026-07-09

More clearances from Stereotaxis, Inc.

view all

K262744 — GenesisX RMN2026-08-27
K253473 — Synchrony2026-04-01
K251792 — Stereotaxis GenesisX RMN with Navigant Workstation (NWS)2025-11-06
K250590 — MAGiC Sweep EP Mapping Catheter2025-07-23
K193147 — Stereotaxis Genesis RMN with Navigant Workstation (NWS) and Cardiodrive System2020-03-05

Adverse events under product code DQK

product code DQK

Death: 10
Injury: 225
Malfunction: 2,123
Other: 2
Total: 2,360

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.